Organogenesis Holdings Inc - Class A logo

ORGO

Organogenesis Holdings Inc - Class A

$4.41

Earnings Summary

Revenue
$98.12Mn
Net Profits
$0.09Mn
Net Profit Margins
0.09%
PE Ratio
8.82

Highlights

Revenue:

Organogenesis Holdings Inc - Class A’s revenue fell -4.32% since last year same period to $98.12Mn in the Q1 2022. On a quarterly growth basis, Organogenesis Holdings Inc - Class A has generated -23.68% fall in its revenue since last 3-months.

Net Profits:

Organogenesis Holdings Inc - Class A’s net profit fell -99.13% since last year same period to $0.09Mn in the Q1 2022. On a quarterly growth basis, Organogenesis Holdings Inc - Class A has generated -99.83% fall in its net profits since last 3-months.

Net Profit Margins:

Organogenesis Holdings Inc - Class A’s net profit margin fell -99.09% since last year same period to 0.09% in the Q1 2022. On a quarterly growth basis, Organogenesis Holdings Inc - Class A has generated -99.78% fall in its net profit margins since last 3-months.

PE Ratio:

Organogenesis Holdings Inc - Class A’s price-to-earnings ratio after this Q1 2022 earnings stands at 8.82.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Organogenesis Holdings Inc - Class A post its latest quarter earnings

EPS Estimate Current Quarter
0.08
EPS Estimate Current Year
0.08

Highlights

EPS Estimate Current Quarter:

Organogenesis Holdings Inc - Class A’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a 60% jump from last quarter’s estimates.

EPS Estimate Current Year:

Organogenesis Holdings Inc - Class A’s earning per share (EPS) estimates for the current year stand at 0.08.

Key Ratios

Key ratios of the Organogenesis Holdings Inc - Class A post its Q1 2022 earnings

Earning Per Share (EPS)
0
Return on Assets (ROA)
0.09
Return on Equity (ROE)
0.33
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Organogenesis Holdings Inc - Class A’s earning per share (EPS) fell -99% since last year same period to 0 in the Q1 2022. This indicates that the Organogenesis Holdings Inc - Class A has generated -99% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Organogenesis Holdings Inc - Class A’s return on assets (ROA) stands at 0.09.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Organogenesis Holdings Inc - Class A’s return on equity (ROE) stands at 0.33.

Dividend Per Share (DPS):

Organogenesis Holdings Inc - Class A declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
0.05
0
-98.6%

Company Information

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Organisation
Organogenesis Holdings Inc - Class A
Headquarters
Canton, Massachusetts, US
Employees
910
Industry
Finance